Table of Contents Table of Contents
Previous Page  244 / 1082 Next Page
Information
Show Menu
Previous Page 244 / 1082 Next Page
Page Background

S231

ESTRO 36 2017

_______________________________________________________________________________________________

Figure 2

Conclusion

DPF can be estimated and constructed adaptively voxel-

by-voxel in human tumor using multiple FDG-PET imaging

obtained during the treatment course. DPF provides a

potential quantitative objective for adaptive DPbN to plan

the best clinical dose, escalate or de-escalate, in human

tumor based on its own radiosensitivity or radioresistance.

OC-0442 Intensity based synthetic CT generation from

standard T2-weighted MR images with three MR

scanners

L. Koivula

1

, L. Wee

2

, J. Dowling

3

, P. Greer

4

, T. Seppälä

1

,

J. Korhonen

1

1

Comprehensive Cancer Center- Helsinki University

Central Hospital, Department of radiation oncolocy,

Helsinki, Finland

2

Danish Colorectal Cancer Center South, Vejle Hospital,

Vejle, Denmark

3

Commonwealth Scientific and Industrial Research

Organisation CSIRO, CSIRO ICT Centre, Brisbane,

Australia

4

Calvary Mater Newcastle Hospital, Radiation Oncology,

Newcastle, Australia

Purpose or Objective

Recent studies have shown feasibility t o conduct the

entire radiotherapy treatment planning workflow relying

solely on magnetic resonance imaging (M RI). Yet, few

hospitals have implemented the MRI-only workflow into

clinical routine. One limiting issue is the requisite

construction of a synthetic computed tomography (sCT)

image. The majority of published sCT generation methods

necessitate inclusion of extra sequences into the

simulation imaging protocol. This study aims to develop an

intensity-based sCT generation method that relies only on

image data from standard T2-weighted sequence. The

work includes images derived from three different

manufacturers’ MR scanners. The primary target group

was prostate, for which T2-weighted images are already

used as standard target delineation images.

Material and Methods

The study utilized a total of 30 standard T2-weighted

images acquired for prostate target delineation in three

different clinics. The imaging was conducted with MR

scanners (GE Optima 1.5T, Philips Ingenia 1.5T, and

Siemens Skyra 3.0T) of each participating clinic by using

their typical clinical settings. Intensity value variations of

the obtained images were studied locally, and compared

to corresponding Hounsfield units (HUs) of a standard CT

image. The data of 21 of the 30 prostate patients was used

to generate conversion models for bony and soft tissues to

transform the MR image into sCT. The models were

optimized separately for the images obtained by each MR

platform. The sCT generation was tested for 9 of the 30

prostate patients by acquiring the conversion algorithms

within and outside an automatically contoured bone

outline. The quality of the produced sCT images was

quantified by HU and dose distribution comparisons

against standard CT images. The treatment planning was

conducted with VMAT.

Results

Figure 1 shows examples of the constructed sCTs with the

original MR images of each scanner. The mean HU

difference for the sCTs was 11 HUs and 90 HUs in the soft

and bone tissue volumes, respectively (n=9). The target

volume dose differences compared to the CTs were within

0.8% in all cases (0.2±0.5% [average±SD, n=9]). Table 1

presents the HU and dose distribution differe nces

between the sCTs and the actual CT images.

Conclusion

This study revealed the feasibility of generating high

quality sCTs directly from intensity values of standard T2-

weighted MR images. The applied sCT generation method

is adjustable for images applied by multiple

manufacturers’ scanners with different clinical settings.

This work can further contribute to wider clinical

implementation of MRI-only based radiotherapy treatment

planning.

Proffered Papers: Optimatisation algorithms for

treatment planning

OC-0443 Robust optimization of VMAT in head and

neck patients

D. Wagenaar

1

, R.G.J. Kierkels

1

, J. Free

1

, J.A.

Langendijk

1

, E.W. Korevaar

1

1

UMCG University Medical Center Groningen,

Department of Radiation Oncology, Groningen, The

Netherlands